medroxyprogesterone has been researched along with Dysgerminoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalli, F; Hansen, H; Klepp, O; Rozencweig, M | 1 |
| Furnari, S; Mattea, E; Pavone-Macaluso, M; Veroux, G | 1 |
2 other study(ies) available for medroxyprogesterone and Dysgerminoma
| Article | Year |
|---|---|
Phase II study of oral medroxyprogesterone acetate in advanced germ cell tumors.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents; Drug Evaluation; Dysgerminoma; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1983 |
Cancer chemotherapy in urology.
Topics: Adenocarcinoma; Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Chlorambucil; Cobalt; Dactinomycin; Dysgerminoma; Female; Fluorouracil; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Papilloma; Prostatic Neoplasms; Teratoma; Testicular Neoplasms; Testosterone; Thiotepa; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vincristine; Wilms Tumor | 1971 |